EIKN
Eikon Therapeutics, Inc. Common Stock
NASDAQ: EIKN · HEALTHCARE · BIOTECHNOLOGY
$9.62
+5.54% today
Updated 2026-04-30
Market cap
$522.71M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.18
Dividend yield
—
52W range
$9 – $17
Volume
0.4M
Eikon Therapeutics, Inc. Common Stock (EIKN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 1
Last 1 quarters
Avg EPS surprise
-47.8%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+7.8%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+7.8%
2026-03-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-30 | $-26.23 | -47.8% | $9.81 | $10.58 | +7.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-17.75 | $-26.23 | -47.8% | — | — |
Frequently asked questions
Has Eikon Therapeutics, Inc. Common Stock beaten earnings estimates?
Eikon Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 0 of its last 1 quarterly reports, with an average EPS surprise of -47.8% over the last 1 quarters.
How does EIKN stock react to earnings?
EIKN stock has moved an average of +7.8% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.